DOVER and QUVER -: New marker combinations to detect and monitor at-risk drinking

被引:11
作者
Berner, Michael M.
Bentele, Michael
Kriston, Levente
Maenz, Constantin
Clement, Hans-Willi
Haerter, Martin
Mundle, Goetz
机构
[1] Freiburg Univ Hosp, Dept Psychiat & Psychotherapy, D-79104 Freiburg, Germany
[2] Univ Tubingen Hosp, Hosp Psychiat & Psychotherapy, Tubingen, Germany
关键词
D O I
10.1111/j.1530-0277.2006.00163.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
At-risk drinking is a common medical problem. "Objective" laboratory tests are widely used, especially in situations where it might be favorable for the patient to dissimulate the existing alcohol problem. In this study, we report a new approach to combine the biological markers % carbohydrate-deficient transferrin (%CDT) and gamma-glutamyltransferase (gamma GT) to increase diagnostic properties to identify patients with at-risk drinking behavior. Fifty-eight general practitioners (GPs) participated in the study at 2 study sites in South-West Germany. Patients filled in a questionnaire that included the Alcohol Use Disorders Identification Test (AUDIT) and gave a blood sample. The GP recorded his assessment about the presence of an alcohol-related disorder in the patient. Screening results of 1 test center were used as a calculation sample. The results at the other site were used to cross-validate the study outcomes. The markers were combined by 2 methods. The first approach used the AUDIT (QUestionnaire VERified; QUVER), and the second was performed using the clinical judgment of the treating GP (DOctor VERified; DOVER). The formulas were calculated using linear and logistic regression models, respectively. A total of 2,940 patients participated in the study, of whom 2,496 completed data sets that could be used for further analysis. In the receiver-operating characteristics (ROC) curves with the reference standard of an AUDIT >= 8, the area under the curve (AUC) of 78.8% for DOVER and 80.6% (QUVER) are in a higher range than the values for gamma-%CDT (75.4%) or gamma-GT (66.3%) and %CDT (74.3%) and suggest a clear superiority of the proposed marker combinations. Regarding the combinations DOVER and QUVER, the cross-validation results were almost identical, with 78.4/78.8% and 80.6/79.5%, respectively. Our study is to date the largest practice-based trial that examines the value of the markers CDT and gamma-GT and their combinations for the screening of at-risk drinking in general practice under routine conditions. Our ROC analysis clearly demonstrated that the combination of the markers gamma-GT and %CDT under routine conditions with a behaviorally oriented reference standard leads to an improvement of diagnostic performance, more so than the use of single markers.
引用
收藏
页码:1372 / 1380
页数:9
相关论文
共 51 条
[1]
Carbohydrate-deficient transferrin, γ-glutamyltransferase, and macrocytic volume as biomarkers of alcohol problems in women [J].
Allen, JP ;
Litten, RZ ;
Fertig, JB ;
Sillanaukee, P .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2000, 24 (04) :492-496
[2]
Laboratory markers carbohydrate-deficient transferrin, γ-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population:: Results from the study of health in Pomerania (SHIP) [J].
Alte, D ;
Luedemann, J ;
Rose, HJ ;
John, U .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (06) :931-940
[3]
Carbohydrate-deficient transferrin and γ-glutamyltransferase for the detection and monitoring of alcohol use:: Results from a multisite study [J].
Anton, RF ;
Lieber, C ;
Tabakoff, B .
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2002, 26 (08) :1215-1222
[4]
Anton RF, 2001, CLIN CHEM, V47, P1769
[5]
Method-dependent characteristics of carbohydrate-deficient transferrin measurements in the follow-up of alcoholics [J].
Anttila, P ;
Järvi, K ;
Latvala, J ;
Niemelä, O .
ALCOHOL AND ALCOHOLISM, 2004, 39 (01) :59-63
[6]
A new modified γ-%CDT method improves the detection of problem drinking:: studies in alcoholics with or without liver disease [J].
Anttila, P ;
Jarvi, K ;
Latvala, J ;
Blake, JE ;
Niemelä, O .
CLINICA CHIMICA ACTA, 2003, 338 (1-2) :45-51
[7]
Babor T.F., 2011, ALCOHOL USE DISORDER, V2nd
[8]
Babor TF., 1989, AUDIT ALCOHOL USE DI
[9]
Bean P, 2001, ALCOHOL CLIN EXP RES, V25, P309
[10]
Screening in brief intervention trials targeting excessive drinkers in general practice: systematic review and meta-analysis [J].
Beich, A ;
Thorsen, T ;
Rollnick, S .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7414) :536-540A